2. Signaling Pathways
  3. Others
  4. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (10876):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-136428S
    Desoxycarbadox-d3
    		99.78%
    Desoxycarbadox-d3 is the deuterium labeled Desoxycarbadox. Desoxycarbadox is a metabolite of Carbadox (HY-B1340). Carbadox is a quinoxaline-di-N-oxide antibiotic compound.
    Desoxycarbadox-d<sub>3</sub>
  • HY-W585918S
    4,4'-Dihydroxydiphenylmethane-d10
    		99.60%
    4,4'-Dihydroxydiphenylmethane-d10 is a deuterium labeled compound.
    4,4'-Dihydroxydiphenylmethane-d<sub>10</sub>
  • HY-B1743AS
    Puromycin-d3 dihydrochloride
    		98.0%
    Puromycin-d3 (dihydrochloride) is the deuterium labeled Puromycin dihydrochloride. Puromycin dihydrochloride (CL13900 dihydrochloride), an aminonucleoside antibiotic, inhibits protein synthesis.
    Puromycin-d<sub>3</sub> dihydrochloride
  • HY-113336S
    15(S)-HETE-d8
    		98.1%
    15(S)-HETE-d8 is the deuterium labeled 15(S)-HETE.
    15(S)-HETE-d<sub>8</sub>
  • HY-N0210S11
    D-Galactose-d2-1
    		99.9%
    D-Galactose-d2-1 is the deuterium labeled D-Galactose. D-Galactose is a natural aldohexose and C-4 epimer of glucose.
    D-Galactose-d<sub>2</sub>-1
  • HY-130187S
    Sapienic acid-d19
    		99.0%
    Sapienic acid-d19 is a deuterated labeled Sapienic acid. Sapienic acid is a fatty acid commonly found on the skin and in mucosa. Sapienic acid has variable antimicrobial activities against Gram-positive and Gram-negative bacteria found on the skin and in the oral cavity. Sapienic acid is active against Streptococcus sanguinis, Streptococcus mitis and Fusobacterium nucleatum with MBC values of 31.3 μg/mL, 375.0 μg/mL and 93.8 μg/mL, respectively.
    Sapienic acid-d<sub>19</sub>
  • HY-13662BS
    (R)-Lansoprazole-d4
    		99.13%
    (R)-Lansoprazole-d4 is deuterium labeled (R)-Lansoprazole. (R)-Lansoprazole is the R enantiomer of Lansoprazole, Lansoprazole (AG 1749) is an orally active proton pump inhibitor which prevents the stomach from producing acid. Lansoprazole (AG 1749) is a potent brain penetrant neutral sphingomyelinase (N-SMase) inhibitor (exosome inhibitor).
    (R)-Lansoprazole-d<sub>4</sub>
  • HY-A0014S
    Ramelteon-d5
    		99.83%
    Ramelteon-d5 is deuterium labeled Ramelteon. Ramelteon is a potent, highly selective, and orally active agonist of MT1/MT2 with Ki values of 14 and 112 pM, respectively. Ramelteon has the potential for the research of insomnia. Ramelteon consistently reduces sleep onset after long-term treatment, with no next-morning residual effects or rebound insomnia or withdrawal symptoms upon discontinuation.
    Ramelteon-d<sub>5</sub>
  • HY-106254S
    Vapendavir-d5
    		99.9%
    Vapendavir-d5 is the deuterium labeled Vapendavir. Vapendavir (BTA798) is a potent enteroviral capsid binder (CB). Vapendavir (BTA798) possesses potent antiviral activity for enterovirus 71 (EV71) replication, with EC50 values of 0.5-1.4 μM in different EV71 strains.
    Vapendavir-d<sub>5</sub>
  • HY-B0372AS
    Bromhexine-d3 hydrochloride
    		99.0%
    Bromhexine-d3 (hydrochloride) is deuterium labeled Bromhexine (hydrochloride). Bromhexine hydrochloride is a potent and specific TMPRSS2 protease inhibitor with an IC50 of 0.75 μM. Bromhexine hydrochloride can prevent and manage SARS-CoV-2 infection. Bromhexine hydrochloride is an autophagy agonist. Bromhexine hydrochloride is a mucolytic cough suppressant and has the potential for a range of respiratory conditions.
    Bromhexine-d<sub>3</sub> hydrochloride
  • HY-15037S2
    Diclofenac-13C6 sodium
    		99.96%
    Diclofenac-13C6 (Sodium) is the 13C6 labeled Diclofenac (Sodium). Diclofenac Sodium (GP 45840) is a potent and nonselective anti-inflammatory agent, acts as a COX inhibitor, with IC50s of 4 and 1.3 nM for human COX-1 and COX-2 in CHO cells, and 5.1 and 0.84 μM for ovine COX-1 and COX-2, respectively. Diclofenac Sodium induces apoptosis of neural stem cells (NSCs) via the activation of the caspase cascade.
    Diclofenac-<sup>13</sup>C<sub>6</sub> sodium
  • HY-143645S
    Glycochenodeoxycholic acid 3-sulfate-d5 disodium
    		99.33%
    Glycochenodeoxycholic acid 3-sulfate-d5 (disodium) is the deuterium labeled Glycochenodeoxycholic acid 3-sulfate disodium.
    Glycochenodeoxycholic acid 3-sulfate-d<sub>5</sub> disodium
  • HY-B0579S2
    Cyclosporin A acetate-d4
    		99.90%
    Cyclosporin A acetate-d4 (Cyclosporine A acetate-d4; Ciclosporin A acetate-d4) is a deuterium labeled Cyclosporin A (HY-B0579). Cyclosporin A (Cyclosporine A) is an immunosuppressant which binds to the cyclophilin and inhibits phosphatase activity of protein phosphatase 2B (PP2B/calcineurin) with an IC50 of 5 nM. Cyclosporin A also inhibits CD11a/CD18 adhesion.
    Cyclosporin A acetate-d<sub>4</sub>
  • HY-W010589S
    L-2-Aminobutyric acid-d3
    		99.9%
    L-2-Aminobutyric acid-d3 is the deuterium labeled L-2-Aminobutyric acid. L-2-Aminobutyric acid is a non-proteinogenic amino acid that exists in human tissues and body fluids. L-2-Aminobutyric acid is formed by the transamination of oxobutyric acid. L-2-Aminobutyric acid can serve as a precursor for anticonvulsant and anti-tuberculosis agents and is a key intermediate in the chemical and pharmaceutical industries.
    L-2-Aminobutyric acid-d<sub>3</sub>
  • HY-W777677
    Bisphenol b-D-glucuronide A-d6
    Bisphenol b-D-glucuronide A-d6 is the deuterium labeled Bisphenol A-β-D-glucuronide (HY-W585982). Bisphenol A-β-D-glucuronide is an inactive metabolite of the plasticizer Bisphenol A (HY-18260).
    Bisphenol b-D-glucuronide A-d<sub>6</sub>
  • HY-N0593S2
    Deoxycholic acid-d6
    		99.70%
    Deoxycholic acid-d6 is the deuterium labeled Deoxycholic acid. Deoxycholic acid is specifically responsible for activating the G protein-coupled bile acid receptor TGR5 that stimulates brown adipose tissue (BAT) thermogenic activity.
    Deoxycholic acid-d<sub>6</sub>
  • HY-W018772S14
    D-Ribose-d5
    		99.10%
    D-Ribose-d5 is the deuterium labeled D-Ribose. D-Ribose is an energy enhancer, and acts as a sugar moiety of ATP, and widely used as a metabolic therapy supplement for chronic fatigue syndrome or cardiac energy metabolism. D-Ribose is active in protein gl
    D-Ribose-d<sub>5</sub>
  • HY-138622S1
    24:0 Lyso PC-d4
    24:0 Lyso PC-d44 is the deuterium labeled 24:0 Lyso PC. 24:0 Lyso PC is a lysophospholipid (LyP). 24:0 Lyso PC could be used for mRNA drug delivery.
    24:0 Lyso PC-d<sub>4</sub>
  • HY-A0023AS
    Alogliptin-13C,d3
    Alogliptin-13C,d3 is the deuterium labeled Alogliptin. Alogliptin is a potent and selective inhibitor of DPP-4.
    Alogliptin-<sup>13</sup>C,d<sub>3</sub>
  • HY-W1128514S
    Triacetoxyborate sodium-d
    		101.37%
    Triacetoxyborate sodium-d is the deuterium labeled Triacetoxyborate sodium.
    Triacetoxyborate sodium-d